Patents by Inventor Holly Turner Reardon

Holly Turner Reardon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9914969
    Abstract: The present invention relates methods to increase the expression of fatty acid desaturases (FADS) and increase cellular and tissue levels of highly unsaturated fatty acids (HUFA) by modulating one or more of the FADS via the action of specific classes of drugs (e.g., statins and LXR agonists). The present invention also relates to methods of treating conditions (e.g., tumor and cancer) involving deficient function of FADS by administering statins and/or LXR agonists. The present invention further relates to methods of determining the need for statins or dietary LCPUFA in subjects.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: March 13, 2018
    Assignee: CORNELL UNIVERSITY
    Inventors: James Thomas Brenna, Holly Turner Reardon, Sesha Durga Kumar Kothapalli
  • Publication number: 20150018378
    Abstract: The present invention relates methods to increase the expression of fatty acid desaturases (FADS) and increase cellular and tissue levels of highly unsaturated fatty acids (HUFA) by modulating one or more of the FADS via the action of specific classes of drugs (e.g., statins and LXR agonists). The present invention also relates to methods of treating conditions (e.g., tumor and cancer) involving deficient function of FADS by administering statins and/or LXR agonists. The present invention further relates to methods of determining the need for statins or dietary LCPUFA in subjects.
    Type: Application
    Filed: January 28, 2013
    Publication date: January 15, 2015
    Inventors: James Thomas Brenna, Holly Turner Reardon, Sesha Durga Kumar Kothapalli